This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Is Ingevity (NGVT) Down 7.4% Since Last Earnings Report?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Flexible Solutions (FSI) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Flexible Solutions' (FSI) Biodegradable Polymers sales rise in Q2 on higher customer orders.
American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.
Koppers (KOP) Earnings Surpass Estimates, Sales Lag in Q2
by Zacks Equity Research
Koppers (KOP) sees record sales in its Railroad and Utility Products and Services segment on higher pricing and increased crosstie and utility poles volumes in Q2.
Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2
by Zacks Equity Research
Ingevity's (NGVT) top line declines in Q2 due to the Performance Chemicals segment's repositioning, which included limiting exposure to specific markets within the Industrial Specialties product line.
Ingevity (NGVT) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -3.81% and 5.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales
by Zacks Equity Research
The addition of a new distribution partner in Europe devoted to Ingevity's (NGVT) Capa biodegradable thermoplastics allows the company to better service its customers in the region.
Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat
by Zacks Equity Research
Hawkins (HWKN) sees strong growth in the Water Treatment segment in the fiscal fourth quarter.
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
American Vanguard's (AVD) U.S. crop business registers strong sales of granular soil insecticides, herbicides and cotton and peanut products in Q1.
Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag
by Zacks Equity Research
Strong results in the Performance Chemicals segment drove Innospec's (IOSP) earnings in Q1.
Valvoline's (VVV) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Valvoline's (VVV) fiscal second-quarter earnings and revenues surpass estimates on higher system-wide same-store sales.
Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.
Linde's (LIN) Q1 Earnings Beat Estimates on Higher Pricing
by Zacks Equity Research
Higher pricing from the Americas segment aids Linde's (LIN) Q1 earnings, offset partially by lower contributions from the Engineering business unit.
Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 40.54% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Wil Higher Uranium Prices Aid Energy Fuels' (UUUU) Q1 Earnings?
by Zacks Equity Research
Energy Fuels' (UUUU) first-quarter 2024 results are likely to reflect increased uranium sales, as the company is expected to have capitalized on the elevated prices witnessed throughout the quarter.
Olin's (OLN) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Olin's (OLN) first-quarter earnings and sales surpass the respective estimates as strong Winchester results offset the weakness in its Chemical businesses.
Air Products (APD) Earnings Beat, Revenues Miss Estimates in Q2
by Zacks Equity Research
Air Products' (APD) fiscal second-quarter earnings surpass estimates while sales miss the same due to lower volumes.
Albemarle (ALB) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost and productivity actions in the first quarter amid headwinds from softer lithium market prices.
Will Lower Production Weigh on Barrick's (GOLD) Q1 Earnings?
by Zacks Equity Research
Lower gold production and higher costs are likely to have affected Barrick's (GOLD) Q1 performance.
WestRock (WRK) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
WestRock's (WRK) Q2 results are likely to reflect lower volumes due to muted customer spending.
Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) Q1 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is expected to have benefited from its innovation-driven investment and pricing and productivity actions in the first quarter amid demand headwinds.
Analysts Estimate AdvanSix (ASIX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AdvanSix (ASIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.